Related Experiment Video

Updated: Jul 19, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Cirrhotic cardiomyopathy

Waleed Al Hamoudi1, Samuel S Lee

  • 1Liver Unit, University of Calgary, Calgary, Alberta, Canada.

Annals of Hepatology
|October 25, 2006
PubMed

Insights

Cirrhotic cardiomyopathy, a heart condition in liver cirrhosis patients, involves hyperdynamic circulation and impaired contractility. Liver transplantation can effectively treat these cardiovascular complications.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Liver cirrhosis presents with diverse cardiovascular abnormalities, including hyperdynamic circulation and impaired ventricular function.
  • These cardiac issues, collectively termed cirrhotic cardiomyopathy, involve structural and electrophysiological changes like QT prolongation.
  • Pathogenesis is multifactorial, involving cardiomyocyte membrane changes, altered signaling pathways, and enhanced inhibitory systems.

Purpose of the Study:

  • To review the characteristics and pathogenic mechanisms of cirrhotic cardiomyopathy.
  • To explore the role of cirrhotic cardiomyopathy in liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS) placement, and hepatorenal syndrome.
  • To discuss the therapeutic implications, particularly the role of liver transplantation.

Main Methods:

  • Literature review of studies on cardiovascular abnormalities in liver cirrhosis.
  • Analysis of pathogenic mechanisms underlying cirrhotic cardiomyopathy.
  • Evaluation of the impact of interventions like liver transplantation and TIPS.

Main Results:

  • Cirrhotic cardiomyopathy is characterized by increased cardiac output, decreased peripheral resistance, impaired contractility, and QT prolongation.
  • It significantly contributes to cardiac dysfunction post-liver transplantation or TIPS and in hepatorenal syndrome.
  • Liver transplantation improves hemodynamic dysfunctions, including cirrhotic cardiomyopathy and QT interval prolongation.

Conclusions:

  • Cirrhotic cardiomyopathy is a distinct clinical entity in liver cirrhosis with significant implications for patient outcomes.
  • Liver transplantation is the definitive treatment for cardiovascular complications associated with liver cirrhosis.
  • Further research into empirical treatments for cirrhotic cardiomyopathy is warranted.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...